Small Molecule API Market Research Report - Global Forecast to 2027

Global Small Molecule API Market Research Report: Information, by Types (Synthetic/Chemical API and Biological API), Application (Cardiovascular, Oncology, Diabetes, Immunological Disorders and others), Manufacturing Method (In-House and Contract) and Region (North America, Europe, Asia-Pacific and the Middle East & Africa) - Forecast To 2027

ID: MRFR/Pharma/0279-CR | August 2019 | Region: Global | 109 pages

Please note that the assessment period of report has been updated from 2019-2027 to 2020-2027. Cordially fill the sample form for updated data.

The Global Small Molecule API Market is expected to register 7.0% CAGR and is projected to reach USD 279,687.1 Million by 2027. Small molecules are the organic compounds having low molecular weight, which is approximately less than 900 Daltons. It includes lipids, monosaccharides, secondary messengers, other natural products and metabolites, drugs, and other xenobiotics.


Any drug is composed of two components or aspects. The first is the actual API or Active Pharmaceutical Ingredients, which is the central ingredient.  Active Pharmaceutical Ingredients are portions of any drug, which are chemically active, which are meant to produce the desired effect in the body.


Market Dynamics


Growing demand for newly developed small molecules drugs. The pharmaceutical small molecule API manufacturing industry is now experiencing a period of rapid change. This change is being driven by factors such as the changing nature of the drugs being made. Small-molecule drugs accounted for 84% of pharmaceutical industry revenues in 2014. In addition, small-molecule drugs still account for approximately two-thirds of the candidates in the current robust pharmaceutical industry. There has been a significant development in the small molecule API manufacturing in the segments such as oncology, cardiovascular, and metabolic disorders. The demand for the small molecule API drugs in such segments in unprecedented.


Global Small Molecule API Market Size, by Application, 2016 (USD Million)  Small Molecule API Market


Source: MRFR Analysis


Segmentation


The global small molecule API market has been segmented into type, application, and manufacturing methods. 


Based on type, the global market is divided into synthetic/chemical API and biological API. The synthetic/chemical API segment accounted for the largest market share of global small molecule API market. Chemical active pharmaceutical ingredients are the synthetic compounds, which need to be produced in a laboratory or manufacturing unit. The production of chemical active pharmaceutical ingredients involves a variety of process steps that must be optimally coordinated.


Based on application, the global market has been segmented into cardiovascular, oncology, diabetes, and immunological disorders. The cardiovascular segment held the maximum share in the small molecule API market in 2015. Small molecules API play an important role in medicinal preparations used for the treatment of heart failure and disorders of vascular tensions. Some examples of cardiovascular API drugs are Propranolol Hydrochloride and Nifedipine.


Based on manufacturing methods, the global market is segmented into in-house manufacturing (Captive) and contract manufacturing (CMO). The in-house manufacturing segment commands a maximum share of small molecules market with 6.6% CAGR. Currently, 80% of all the drugs are made of small molecules.


Key Players


The major players in the global small molecule API market are Albemarle Corporation (North Carolina), Allergan plc (Ireland), AUROBINDO PHARMA (India), Cambrex Corporation (US), Dr. Reddy’s Laboratories Ltd (India), GlaxoSmithKline plc (UK), Lonza (Switzerland), Merck Sharp & Dohme Corp. (US), Mylan N.V.(US), Novartis AG(Basel-Stadt), Pfizer Inc.(New York), Siegfried AG (Switzerland), Sun Pharmaceutical Industries Ltd (India), and Teva Pharmaceutical Industries Ltd (Israel).


Some of the key strategies followed by the players operating in the global small molecule API market are adopting various strategies to expand their small molecule API business and enhance their market share.


Global Small Molecule API Market Share, by Region, 2016 (%)  Small Molecule API Market


Source: MRFR Analysis


Regional Analysis


The global small molecule API market, based on region, is segmented into North America, Europe, Asia-Pacific, and the Middle East & Africa.


North America accounted for the largest share in the small molecule API market. The active pharmaceutical ingredients market in the region is being changed as large pharmaceutical organizations dedicate assets increasingly to the improvement of biologic solutions.


Europe accounted for the third-largest regional market owing to the initiatives that have been taken to supporting generic drug growth with pricing and reimbursement, as CMOs expected to account for the majority of the manufacturing activity providing accurate understanding in the market. Germany accounted for the largest market share in the European small molecule API market, registering USD 7,435.9 million in revenue in 2015. Asia-Pacific is expected to accomplish the most elevated development in the global small molecule API market during the forecast period on account of the populace demographics in this geography. According to BioPharm International, India as of now accounts for roughly 8% of the worldwide pharmaceutical generation. However, the Middle East & Africa is expected to observe slow growth due to less exposure to healthcare services and stringent government rules and regulations. The market for small molecule API in Africa is growing at a steady pace.


Key Updates



  • In March 2015, Patheon acquired Irix (Florence, SC), a mid-size API manufacturer with development and commercial capabilities. The acquisition added small-molecule capabilities to Patheon’s offerings in large-molecule API and dosage forms.



  • In July 2015, AMRI announced it would acquire Gadea Pharmaceutical Group (Valladolid, Spain), a specialist in hormone and steroid APIs.



  • In August 2016, Allergan Plc announced the acquisition of Eye Care Company ForSight VISION5 Adding Peri-Ocular Ring Technology to its portfolio of innovative eye health products.



  • In June 2016, Albemarle Corporation announced the definitive agreement to sell its Chemetall Surface Treatment business to BASF in a cash transaction valued at approximately USD 3.2 billion.


Market Segmentation


Global Small Molecule API Market, by Type



  • Synthetic/Chemical API

  • Biological API


Small Molecule API Market, by Application



  • Cardiovascular

  • Oncology

  • Diabetes

  • Immunological disorders


Global Small Molecule API Market, by Manufacturing Methods



  • In-House Manufacturing

  • Contract Manufacturing


Global Small Molecule API Market, by Region



  • North America

    • US

    • Canada





  • Europe

    • Western Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Rest of Europe





  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific





  • Middle East & Africa

    • Middle East

    • Africa




Available Additional Customizations



  • Additional Companies

    • Gilead Sciences, Inc.

    • Advanced Brain Monitoring

    • Amneal Pharmaceuticals LLC.

    • Breckenridge Pharmaceutical, Inc.

    • Lupin Pharmaceuticals, Inc.

    • Camber Pharmaceuticals, Inc.




Intended Audience



  • Pharmaceutical companies

  • Contract manufacturing organizations  

  • Research and academic institutes

  • Government research organizations

  • Hospitals and clinics

  • Regulatory agencies



Frequently Asked Questions (FAQ) :


The CAGR would be 7% during the forecast period of 2020 to 2027.

small molecule API market valuation would be USD 279,687.1 million.

small molecule API market has segments like diabetes, oncology, cardiovascular, and immunological disorders.

The segments are in-house manufacturing (Captive) and contract manufacturing (CMO).

The types included are synthetic/chemical API and biological API.

1 INTRODUCTION

1.1 DEFINITION 12

1.2 SCOPE OF STUDY 12

1.2.1 RESEARCH OBJECTIVE 12

1.2.2 ASSUMPTIONS & LIMITATIONS 13

1.2.2.1 ASSUMPTIONS 13

1.2.2.2 LIMITATIONS 13

1.3 MARKET STRUCTURE: 13

2 RESEARCH METHODOLOGY

2.1 RESEARCH PROCESS: 14

2.2 PRIMARY RESEARCH 15

2.3 SECONDARY RESEARCH: 15

3 MARKET DYNAMICS

3.1 DRIVERS 16

3.1.1 GROWING DEMAND FOR NEWLY DEVELOPED SMALL MOLECULES DRUGS 16

3.1.2 GROWING TREND OF OUTSOURCING 16

3.1.3 GROWING PHARMACEUTICAL INDUSTRY IN DEVELOPING NATIONS 17

3.2 RESTRAINTS 17

3.2.1 AUSTERITY MEASURES IN EUROPE 17

3.3 OPPORTUNITIES 17

3.4 MACROECONOMIC INDICATORS 18

4 MARKET FACTOR ANALYSIS

4.1 PORTERS FIVE FORCES MODEL 19

4.2 BARGAINING POWER OF SUPPLIERS 20

4.3 BARGAINING POWER OF BUYERS 20

4.4 THREAT OF NEW ENTRANTS 20

4.5 THREAT OF SUBSTITUTES 20

4.6 INTENSITY OF RIVALRY 20

5 SMALL MOLECULES API, BY TYPE

5.1 SYNTHETIC/CHEMICAL API 22

5.2 BIOLOGICAL API 23

6 SMALL MOLECULE API MARKET, BY APPLICATION

6.1 CARDIOVASCULAR 27

6.2 ONCOLOGY 28

6.3 DIABETES 29

6.4 IMMUNOLOGICAL DISORDERS 30

7 SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS

7.1 IN-HOUSE MANUFACTURING 33

7.2 CONTRACT MANUFACTURING 34

7.2.1 INTRODUCTION 34

8 GLOBAL SMALL MOLECULE API MARKET, BY REGION

8.1 NORTH AMERICA 39

SMALL MOLECULES API, BY TYPE

SMALL MOLECULE API MARKET, BY APPLICATION

SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS

8.1.1 INTRODUCTION 40

8.2 EUROPE 46

SMALL MOLECULES API, BY TYPE

SMALL MOLECULE API MARKET, BY APPLICATION

SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS

8.2.1 INTRODUCTION 47

8.3 ASIA-PACIFIC 58

SMALL MOLECULES API, BY TYPE

SMALL MOLECULE API MARKET, BY APPLICATION

SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS

8.3.1 INTRODUCTION 59

8.4 MIDDLE EAST & AFRICA 72

SMALL MOLECULES API, BY TYPE

SMALL MOLECULE API MARKET, BY APPLICATION

SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS

8.4.1 INTRODUCTION 76

9 COMPETITIVE LANDSCAPE

9.1 MAJOR STRATEGIES ADOPTED BY MARKET PLAYERS 77

9.1.1 STRATEGIC PARTNERSHIP 78

9.1.2 MERGER & ACQUISITION 78

10 COMPANY PROFILE

10.1 ALBEMARLE CORPORATION 80

10.1.1 OVERVIEW 80

10.1.2 PRODUCT OVERVIEW 80

10.1.3 FINANCIALS 81

10.1.4 KEY DEVELOPMENTSS 81

10.2 ALLERGAN PLC 82

10.2.1 OVERVIEW 82

10.2.2 PRODUCT OVERVIEW 82

10.2.3 FINANCIALS 83

10.2.4 KEY DEVELOPMENTSS 83

10.3 AUROBINDO PHARMA 84

10.3.1 OVERVIEW 84

10.3.2 PRODUCT OVERVIEW 84

10.3.3 FINANCIALS 85

10.3.4 STRATEGIES 85

10.3.5 KEY DEVELOPMENTS 85

10.4 CAMBREX CORPORATION 86

10.4.1 OVERVIEW 86

10.4.2 PRODUCT OVERVIEW 86

10.4.3 FINANCIALS 87

10.4.4 KEY DEVELOPMENTS 87

10.5 DR. REDDY’S LABORATORIES LTD. 88

10.5.1 OVERVIEW 88

10.5.2 PRODUCT OVERVIEW 88

10.5.3 FINANCIALS 89

10.5.4 KEY DEVELOPMENTS 89

10.6 GLAXOSMITHKLINE PLC 90

10.6.1 OVERVIEW 90

10.6.2 PRODUCT OVERVIEW 90

10.6.3 FINANCIALS 91

10.6.4 STRATEGIES 91

10.6.5 KEY DEVELOPMENTS 92

10.7 LONZA 92

10.7.1 OVERVIEW 92

10.7.2 PRODUCT OVERVIEW 92

10.7.3 FINANCIALS 93

10.7.4 STRATEGIES 93

10.7.5 KEY DEVELOPMENTS 94

10.8 MERCK SHARP & DOHME CORP. 94

10.8.1 OVERVIEW 94

10.8.2 PRODUCT OVERVIEW 95

10.8.3 FINANCIAL 95

10.8.4 KEY DEVELOPMENTS 96

10.9 MYLAN N.V. 96

10.9.1 OVERVIEW 96

10.9.2 PRODUCT OVERVIEW 97

10.9.3 FINANCIALS 97

10.9.4 KEY DEVELOPMENTS 98

10.10 NOVARTIS AG 98

10.10.1 OVERVIEW 98

10.10.2 PRODUCT OVERVIEW 99

10.10.3 FINANCIALS 99

10.10.4 STRATEGIES 99

10.10.5 DEVELOPMENTS 100

10.11 PFIZER INC. 100

10.11.1 OVERVIEW 100

10.11.2 PRODUCT OVERVIEW 101

10.11.3 FINANCIALS 101

10.11.4 KEY DEVELOPMENTS 102

10.12 SIEGFRIED AG 102

10.12.1 OVERVIEW 102

10.12.2 PRODUCT OVERVIEW 102

10.12.3 FINANCIALS 103

10.12.4 KEY DEVELOPMENTS 103

10.13 SUN PHARMACEUTICAL INDUSTRIES LTD. 104

10.13.1 OVERVIEW 104

10.13.2 PRODUCT OVERVIEW 104

10.13.3 FINANCIALS 105

10.13.4 KEY DEVELOPMENTS 105

10.14 TEVA PHARMACEUTICAL INDUSTRIES LTD 106

10.14.1 OVERVIEW 106

10.14.2 PRODUCT OVERVIEW 106

10.14.3 FINANCIALS 107

10.14.4 STRATEGIES 107

10.14.5 KEY DEVELOPMENTS 108

11 LIST OF TABLES

TABLE 1 GLOBAL SMALL MOLECULE API MARKET, BY TYPE, 2020–2027 (USD MILLION) 22

TABLE 2 GLOBAL SYNTHETIC/CHEMICAL API MARKET, BY REGION, 2020–2027 (USD MILLION) 23

TABLE 3 GLOBAL BIOLOGICAL API MARKET, BY REGION, 2020–2027 (USD MILLION) 24

TABLE 4 GLOBAL SMALL MOLECULE API MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 26

TABLE 5 GLOBAL SMALL MOLECULE API MARKET: CARDIOVASCULAR, BY REGION, 2020–2027 (USD MILLION) 27

TABLE 6 GLOBAL SMALL MOLECULE API MARKET: ONCOLOGY, BY REGION, 2020–2027 (USD MILLION) 28

TABLE 7 GLOBAL SMALL MOLECULE API MARKET: DIABETES, BY REGION, 2020–2027 (USD MILLION) 29

TABLE 8 GLOBAL SMALL MOLECULE API MARKET: IMMUNOLOGICAL DISORDERS, BY REGION, 2020–2027 (USD MILLION) 30

TABLE 9 GLOBAL SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS, 2020–2027 (USD MILLION) 32

TABLE 10 GLOBAL SMALL MOLECULE API MARKET, BY IN-HOUSE MANUFACTURING, 2020–2027 (USD MILLION) 33

TABLE 11 GLOBAL SMALL MOLECULE API MARKET, BY CONTRACT MANUFACTURING, 2020–2027 (USD MILLION) 34

TABLE 12 GLOBAL SMALL MOLECULE API MARKET, BY REGION, 2020–2027 (USD MILLION) 38

TABLE 13 NORTH AMERICA SMALL MOLECULE API MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 39

TABLE 14 NORTH AMERICA SMALL MOLECULE API MARKET, BY TYPE, 2020–2027 (USD MILLION) 40

TABLE 15 NORTH AMERICA SMALL MOLECULE API MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 41

TABLE 16 NORTH AMERICA SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD, 2020–2027 (USD MILLION) 42

TABLE 17 US SMALL MOLECULE API MARKET, BY TYPE, 2020–2027 (USD MILLION) 43

TABLE 18 US SMALL MOLECULE API MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 44

TABLE 19 US SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS, 2020–2027 (USD MILLION) 44

TABLE 20 CANADA SMALL MOLECULE API MARKET, BY TYPE, 2020–2027 (USD MILLION) 45

TABLE 21 CANADA SMALL MOLECULE API MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 45

TABLE 22 CANADA SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS, 2020–2027 (USD MILLION) 46

TABLE 23 EUROPE SMALL MOLECULE API MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 47

TABLE 24 EUROPE SMALL MOLECULE API MARKET, BY TYPE, 2020–2027 (USD MILLION) 48

TABLE 25 EUROPE SMALL MOLECULE API MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 49

TABLE 26 EUROPE SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD, 2020–2027 (USD MILLION) 50

TABLE 27 GERMANY SMALL MOLECULE API MARKET, BY TYPE, 2020–2027 (USD MILLION) 51

TABLE 28 GERMANY SMALL MOLECULE API MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 51

TABLE 29 GERMANY SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD, 2020–2027 (USD MILLION) 52

TABLE 30 FRANCE SMALL MOLECULE API MARKET, BY TYPE, 2020–2027 (USD MILLION) 52

TABLE 31 FRANCE SMALL MOLECULE API MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 53

TABLE 32 FRANCE SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD, 2020–2027 (USD MILLION) 53

TABLE 33 UK SMALL MOLECULE API MARKET, BY TYPE, 2020–2027 (USD MILLION) 54

TABLE 34 UK SMALL MOLECULE API MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 54

TABLE 35 UK SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD, 2020–2027 (USD MILLION) 55

TABLE 36 ITALY SMALL MOLECULE API MARKET, BY TYPE, 2020–2027 (USD MILLION) 55

TABLE 37 ITALY SMALL MOLECULE API MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 56

TABLE 38 ITALY SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD, 2020–2027 (USD MILLION) 56

TABLE 39 SPAIN SMALL MOLECULE API MARKET, BY TYPE, 2020–2027 (USD MILLION) 57

TABLE 40 SPAIN SMALL MOLECULE API MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 57

TABLE 41 SPAIN SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD, 2020–2027 (USD MILLION) 58

TABLE 42 ASIA-PACIFIC SMALL MOLECULE API MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 59

TABLE 43 ASIA-PACIFIC SMALL MOLECULE API MARKET, BY TYPE, 2020–2027 (USD MILLION) 60

TABLE 44 ASIA-PACIFIC SMALL MOLECULE API MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 61

TABLE 45 ASIA-PACIFIC SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS, 2020–2027 (USD MILLION) 62

TABLE 46 JAPAN SMALL MOLECULE API MARKET, BY TYPE, 2020–2027 (USD MILLION) 63

TABLE 47 JAPAN SMALL MOLECULE API MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 63

TABLE 48 JAPAN SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS, 2020–2027 (USD MILLION) 64

TABLE 49 CHINA SMALL MOLECULE API MARKET, BY TYPE, 2020–2027 (USD MILLION) 64

TABLE 50 CHINA SMALL MOLECULE API MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 65

TABLE 51 CHINA SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS, 2020–2027 (USD MILLION) 65

TABLE 52 INDIA SMALL MOLECULE API MARKET, BY TYPE, 2020–2027 (USD MILLION) 66

TABLE 53 INDIA SMALL MOLECULE API MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 66

TABLE 54 INDIA SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS, 2020–2027 (USD MILLION) 67

TABLE 55 SOUTH KOREA SMALL MOLECULE API MARKET, BY TYPE, 2020–2027 (USD MILLION) 68

TABLE 56 SOUTH KOREA SMALL MOLECULE API MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 68

TABLE 57 SOUTH KOREA SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS, 2020–2027 (USD MILLION) 69

TABLE 58 AUSTRALIA SMALL MOLECULE API MARKET, BY TYPE, 2020–2027 (USD MILLION) 70

TABLE 59 AUSTRALIA SMALL MOLECULE API MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 70

TABLE 60 AUSTRALIA SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS, 2020–2027 (USD MILLION) 71

TABLE 61 MIDDLE EAST & AFRICA SMALL MOLECULE API MARKET, BY REGION, 2020–2027 (USD MILLION) 72

TABLE 62 MIDDLE EAST & AFRICA SMALL MOLECULE API MARKET, BY TYPE, 2020–2027 (USD MILLION) 73

TABLE 63 MIDDLE EAST & AFRICA SMALL MOLECULE API MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 74

TABLE 64 MIDDLE EAST & AFRICA SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS, 2020–2027 (USD MILLION) 75

12 LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS 14

FIGURE 2 PORTERS FIVE FORCES MODEL 19

FIGURE 3 GLOBAL SMALL MOLECULE API MARKET, BY TYPE 22

FIGURE 4 GLOBAL SMALL MOLECULE API MARKET, BY APPLICATION 26

FIGURE 5 GLOBAL SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS 32

FIGURE 6 CONTRACT MANUFACTURING ORGANIZATIONS: MARKET SHARE ANALYSIS (%) 35

FIGURE 7 GLOBAL SMALL MOLECULE API MARKET, BY REGION 38

FIGURE 8 NORTH AMERICA SMALL MOLECULE API MARKET, BY COUNTRY (%) 39

FIGURE 9 NORTH AMERICA SMALL MOLECULE API MARKET, BY TYPE 40

FIGURE 10 NORTH AMERICA SMALL MOLECULE API MARKET, BY APPLICATION 41

FIGURE 11 NORTH AMERICA SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD 42

FIGURE 12 EUROPE SMALL MOLECULE API MARKET, BY COUNTRY (%) 46

FIGURE 13 EUROPE SMALL MOLECULE API MARKET, BY TYPE 48

FIGURE 14 EUROPE SMALL MOLECULE API MARKET, BY APPLICATION 49

FIGURE 15 EUROPE SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD 50

FIGURE 16 ASIA-PACIFIC SMALL MOLECULE API MARKET, BY COUNTRY (%) 58

FIGURE 17 ASIA-PACIFIC SMALL MOLECULE API MARKET, BY TYPE 60

FIGURE 18 ASIA-PACIFIC SMALL MOLECULE API MARKET, BY APPLICATION 61

FIGURE 19 ASIA-PACIFIC SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS 62

FIGURE 20 MIDDLE EAST & AFRICA SMALL MOLECULE API MARKET, BY COUNTRY (%) 72

FIGURE 21 MIDDLE EAST & AFRICA SMALL MOLECULE API MARKET, BY TYPE 73

FIGURE 22 MIDDLE EAST & AFRICA SMALL MOLECULE API MARKET, BY APPLICATION 74

FIGURE 23 MIDDLE EAST & AFRICA SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS 75

FIGURE 24 GLOBAL SMALL MOLECULE API MARKET: COMPANY SHARE ANALYSIS, 2020 (%) 77